Triamcinolone versus inner-limiting membrane peeling in persistent diabetic macular edema (TIME study): Design issues and implications

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 12, 2007, Pages 1781-1787

  Joussen, Antonia M ^a   Weiss, Claudia ^b   Bauer, Diana ^b   Hilgers, Ralf Dieter ^b  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Diabetic macular edema; ILM peeling; Randomized prospective trial; Triamcinolene

Indexed keywords

CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT; TRIAMCINOLONE;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DRUG EFFICACY; EUROPE; EYE SURGERY; FOLLOW UP; HUMAN; INNER LIMITING MEMBRANE PEELING METHOD; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MULTICENTER STUDY; OUTCOME ASSESSMENT; PHYSICIAN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SURGEON; SURGICAL TECHNIQUE; TREATMENT DURATION; TREATMENT INDICATION; VISUAL ACUITY; VITRECTOMY;

DIABETIC RETINOPATHY; ENDPOINT DETERMINATION; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULAR EDEMA; OPHTHALMOLOGIC SURGICAL PROCEDURES; PROSPECTIVE STUDIES; RESEARCH DESIGN; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 36348949597     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-007-0640-3     Document Type: Article

References (24)

1. Pendergast SD, Hassan TS, Williams GA et al (2000) Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophthalmol 130:178-186
2. Harbour JW, Smiddy WE, Flynn HW Jr, Rubsamen PE (1996) Vitrecxtomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 121:405-413
3. Ikeda T, Sato K, Katano T, Hayashi Y (2000) Improved visual acuity following pars plana vitrectomy for diabetic cystoid macular edema and detached posterior hyaloid. Retina 20:220-222
4. Micelli Ferrari T, Cardascia N, Durante G, Vetrugno M, Cardia L (1999) Pars plana vitrectomy in diabetic macular edema. Doc Ophthalmol 97:471-474
5. Haritoglou C, Gass CA, Schaumberger M, Ehrt O, Gandorfer A, Kampik A (2001) Macular changes after peeling of the internal limiting membrane in macular hole surgery. Am J Ophthalmol 132:363-368
6. Jonas JB, Sofker A (2001) Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 132:425-427
7. Martidis A, Duker JS, Greenberg PB et al (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920-927
8. Ferris FL, Kassoff A, Bresnick GH, Bailey I (1982) New visual acuity charts for clinical research. Am J Ophthalmol 94:91-96
9. Radner W, Obermayer W, Richter-Mueksch S, Willinger U, Velikay-Parel M, Eisenwort B (2002) The validity and reliability of short German sentences for measuring reading speed. Graefes Arch Clin Exp Ophthalmol 240:461-467
10. Chylack LT Jr, Wolfe JK, Singer DM et al (1993) The lens opacities classification system III. The longitudinal study of cataract study group. Arch Ophthalmol 111:831-836
11. Gandorfer A, Messmer EM, Ulbig MW, Kampik A (2000) Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 20:126-133
12. Cohen J (1997) Statistical power analysis for the behavioral sciences. Academic Press, New York
13. Snapinn SM (1992) Monitoring clinical trials with a conditional probability stopping rule. Stat Med 11:659-672
14. Rom P, Costello RJ, Connell LT (1994) On closed test procedures for dose-response analysis. Stat Med 13:1583-1596
15. Radetzky S, Walter P, Fauser S, Koizumi K, Kirchhof B, Joussen AM (2004) Visual outcome of patients with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol 242:273-278
16. Mochizuki Y, Hata Y, Enaida H et al (2006) Evaluating adjunctive surgical procedures during vitrectomy for diabetic macular edema. Retina 26:143-148
17. Patel JI, Hykin PG, Schadt M, Luong V, Fitzke F, Gregor ZJ (2006) Pars plana vitectomy with an without peeling of the inner limiting membrane for diabetic macular edema. Retina 26:5-13
18. Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Ffytche TJ, Marshall J (2001) Intravitreal triamcinolone for uveitic cystoid macular edema: An optical coherence tomography study. Ophthalmology 108:765-772
19. Young S, Larkin G, Branley M, Lightman S (2001) Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Experiment Ophthalmol 29:2-6
20. Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E (2002) Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 86:247-248
21. Chieh JJ, Roth DB, Liu M, Blemnont J, Nelson M, Regillo C, Martidis A (2005) Intravitreal triamcinolone acetonide for diabetic macular edema. Retina 25:828-834
22. Larsson J, Zhu M, Sutter F, Gillies MC (2005) Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone. Am J Ophthalmol 139:802-806
23. Massin P, Audren F, Haouchine B et al (2004) Intravitreal tiramcinolone acetonide for diabetic diffuse macular edema: Preliminary results of a prospective controlled trial. Ophthalmology 111:218-224
24. Stifter E, Weghaupt H, Benesch T, Thaler A, Radner W (2005) Discriminative power of reading tests to differentiate visual impairment caused by cataract and age-related macular degeneration. J Cataract Refract Surg 31:2111-2119